Citation

Huang Q., Johnson T., Bailey S., Brooun A., Bunker K., Burke B., Collins M., Cook A., Cui J., Dack K., Deal J., Deng Y., Dinh D., Engstrom L., He M., Hoffman J., Hoffman R., Johnson P., Kania R., Lam H., Lam J., Le P., Li Q., Lingardo L., Liu W., Lu M., McTigue M., Palmer C., Richardson P., Sach N., Shen H., Smeal T., Smith G., Stewart A., Timofeevski S., Tsaparikos K., Wang H., Zhu H., Zhu J., Zou H., Edwards M.: Design of Potent and Selective Inhibitors to Overcome Clinical Anaplastic Lymphoma Kinase Mutations Resistant to Crizotinib. Journal of Medicinal Chemistry, Volume 57 (4), 2014

Authors

Qinhua Huang, Ted W. Johnson, Simon Bailey, Alexei Brooun, Kevin D. Bunker, Benjamin J. Burke, Michael R. Collins, Andrew S. Cook, J. Jean Cui, Kevin N. Dack, Judith G. Deal, Ya-Li Deng, Dac Dinh, Lars D. Engstrom, Mingying He, Jacqui Hoffman, Robert L. Hoffman, Patrick S. Johnson, Robert S. Kania, Hieu Lam, Justine L. Lam, Phuong T. Le, Qiuhua Li, Laura Lingardo, Wei Liu, Melissa West Lu, Michele McTigue, Cynthia L. Palmer, Paul F. Richardson, Neal W. Sach, Hong Shen, Tod Smeal, Graham L. Smith, Albert E. Stewart, Sergei Timofeevski, Konstantinos Tsaparikos, Hui Wang, Huichun Zhu, Jinjiang Zhu, Helen Y. Zou, Martin P. Edwards

Journal

Journal of Medicinal Chemistry

Year

2014

DOI

10.1021/jm401805h

Machine-readable

REST APIRDF